Q Fever News and Research

RSS

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Researchers demonstrated the anti-spike antibody response to SARS-CoV-2 infection and further estimated the acute SARS-CoV-2 infection-induced Ab activity against recently emerged variants like Omicron.

10 Mar 2022

Two years in, covid leaves Montana public health officials feeling ‘watched’

After covid-19 arrived in Park County, Montana, the local health officer, Dr. Laurel Desnick, became the face of pandemic measures and the focus of attention as never before.

10 Mar 2022

Incidence of myocarditis and pericarditis following COVID-19 vaccination

Researchers used a cohort design for the estimation of adjusted hazard ratios for hospitalized or fatal myocarditis/pericarditis following the first and second dose of BNT162b2 and ChAdOx1 vaccines.

10 Mar 2022

Aerial images and computer program locate pools, water tanks to identify areas vulnerable to dengue

Brazilian researchers have developed a computer program that locates swimming pools and rooftop water tanks in aerial photographs with the aid of artificial intelligence to help identify areas vulnerable to infestation by Aedes aegypti, the mosquito that transmits dengue, zika, chikungunya and yellow fever.

9 Mar 2022

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Researchers assessed the levels of neutralizing antibodies in coronavirus disease patients.

9 Mar 2022

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Prime Minister Boris Johnson today announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42million to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 - the virus that causes COVID-19 - as well as other major coronaviruses, including those that cause SARS and MERS.

8 Mar 2022

Biomedical characterization of quantitative proteomics in a hospitalized cohort of COVID-19 patients

A recent study assessed neutrophil extracellular trap formation and antiviral host response in high-risk COVID-19 patients.

8 Mar 2022

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

A recent study predicted the efficacy of the SOBERANA 02 and SOBERANA Plus COVID-19 vaccines in children.

8 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

The findings of the study demonstrated the higher occurrence of more severe cases during the predominance of the Alpha variant as compared to the Delta wave after adjusting the regression model for effects like age and status of vaccination.

7 Mar 2022

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

A new study discusses the outcomes of idiopathic pulmonary fibrosis patients with confirmed SARS-CoV-2 infection.

6 Mar 2022

Study identifies olfactory dysfunction as an early symptom of COVID-19

In a new study, scientists researched olfactory loss and dysfunction among COVID-19 patients to objectively characterize it as a symptom of COVID-19.

1 Mar 2022

Study reveals new way viruses trigger autoimmunity

Autoimmune diseases such as rheumatoid arthritis and Type 1 diabetes are thought to arise when people with a genetic susceptibility to autoimmunity encounter something in the environment that triggers their immune systems to attack their own bodies.

28 Feb 2022

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

A team of scientists from Germany has recently conducted a serological screening on wild animals to assess seroprevalence against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other pathogenic viruses related to domestic ruminants.

27 Feb 2022

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Researchers evaluated the efficacy of SARS-CoV-2 vaccines made by Pfizer, Jansen, and Moderna against symptomatic and asymptomatic COVID-19 cases.

25 Feb 2022

UK funding will support CEPI’s drive to accelerate vaccine development

The UK will pledge £160 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to speed up vaccine development, as the Foreign Secretary and Health and Social Care Secretary urge international partners to step up and support this vital work.

24 Feb 2022

Q Fever News and Research

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Two years in, covid leaves Montana public health officials feeling ‘watched’

Incidence of myocarditis and pericarditis following COVID-19 vaccination

Aerial images and computer program locate pools, water tanks to identify areas vulnerable to dengue

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Biomedical characterization of quantitative proteomics in a hospitalized cohort of COVID-19 patients

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

Study identifies olfactory dysfunction as an early symptom of COVID-19

Study reveals new way viruses trigger autoimmunity

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

UK funding will support CEPI’s drive to accelerate vaccine development

Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

Study reports persistent SARS-CoV-2 lingering within tissues of patients with long COVID

Antibody levels against SARS-CoV-2 spike protein up to 12 months after COVID-19 infection in non-vaccinated individuals

Study shows BCG vaccine provides no protection against SARS-CoV-2 in mice and hamsters

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News